182 related articles for article (PubMed ID: 24818785)
21. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database.
Lucchesi KM; Grant R; Kahle KT; Marks AM; DiLuna ML
J Neurooncol; 2016 Oct; 130(1):133-140. PubMed ID: 27423644
[TBL] [Abstract][Full Text] [Related]
22. The significance of radiotherapy treatment duration in intracranial ependymoma.
Paulino AC; Wen BC
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):585-9. PubMed ID: 10837939
[TBL] [Abstract][Full Text] [Related]
23. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
24. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
25. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy.
Liu KX; Indelicato DJ; Paulino AC; Looi WS; Catalano PJ; Chintagumpala MM; Gallotto SL; Marcus KJ; Haas-Kogan DA; Tarbell NJ; MacDonald SM; Mahajan A; Yock TI
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1174-1180. PubMed ID: 37437812
[TBL] [Abstract][Full Text] [Related]
26. Surgical Treatment of Spinal Ependymomas: Experience in 49 Patients.
Wild F; Hartmann C; Heissler HE; Hong B; Krauss JK; Nakamura M
World Neurosurg; 2018 Mar; 111():e703-e709. PubMed ID: 29309981
[TBL] [Abstract][Full Text] [Related]
27. Long term outcome with post-operative radiation therapy for spinal canal ependymoma.
Wahab SH; Simpson JR; Michalski JM; Mansur DB
J Neurooncol; 2007 May; 83(1):85-9. PubMed ID: 17206474
[TBL] [Abstract][Full Text] [Related]
28. Outcome predictors in the management of spinal myxopapillary ependymoma: an integrative survival analysis.
Kukreja S; Ambekar S; Sharma M; Sin AH; Nanda A
World Neurosurg; 2015 May; 83(5):852-9. PubMed ID: 25108296
[TBL] [Abstract][Full Text] [Related]
29. Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma.
Looi WS; Indelicato DJ; Mailhot Vega RB; Morris CG; Sandler E; Aldana PR; Bradley JA
Pediatr Blood Cancer; 2021 Mar; 68(3):e28820. PubMed ID: 33226179
[TBL] [Abstract][Full Text] [Related]
30. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
31. Spinal cord ependymoma in children--results of postoperative radiotherapy.
Pędziwiatr K; Skowrońska-Gardas A; Chojnacka M
Radiother Oncol; 2013 Feb; 106(2):181-5. PubMed ID: 23490267
[TBL] [Abstract][Full Text] [Related]
32. Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.
Hongo H; Takai K; Komori T; Taniguchi M
J Neurosurg Spine; 2018 Oct; 30(1):133-139. PubMed ID: 30485241
[TBL] [Abstract][Full Text] [Related]
33. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
34. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
[TBL] [Abstract][Full Text] [Related]
35. An integrative analysis of treatment, outcomes and prognostic factors for primary spinal anaplastic ependymomas.
Chen P; Sui M; Ye J; Wan Z; Chen F; Luo C
J Clin Neurosci; 2015 Jun; 22(6):976-80. PubMed ID: 25769252
[TBL] [Abstract][Full Text] [Related]
36. Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.
Bates JE; Choi G; Milano MT
J Neurooncol; 2016 Sep; 129(2):251-8. PubMed ID: 27306443
[TBL] [Abstract][Full Text] [Related]
37. Spinal cord ependymomas: a retrospective analysis of 59 cases.
Waldron JN; Laperriere NJ; Jaakkimainen L; Simpson WJ; Payne D; Milosevic M; Wong CS
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):223-9. PubMed ID: 8407395
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review.
Abdallah A; Emel E; Gündüz HB; Sofuoğlu ÖE; Asiltürk M; Abdallah BG
World Neurosurg; 2020 Apr; 136():e245-e261. PubMed ID: 31899399
[TBL] [Abstract][Full Text] [Related]
39. Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.
Koshy M; Rich S; Merchant TE; Mahmood U; Regine WF; Kwok Y
J Neurooncol; 2011 Dec; 105(3):583-90. PubMed ID: 21637963
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
